WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda

Joseph Kagaayi, Fredrick Makumbi, Gertrude Nakigozi, Maria J. Wawer, Ronald H. Gray, David Serwadda, Steven J. Reynolds

Research output: Contribution to journalArticlepeer-review

Abstract

The ability of WHO clinical staging to predict CD4 cell counts of 200 cells/μl or less was evaluated among 1221 patients screened for antiretroviral therapy (ART). Sensitivity was 51% and specificity was 88%. The positive predictive value was 64% and the negative predictive value was 81%. Clinical criteria missed half the patients with CD4 cell counts of 200 cells/μl or less, highlighting the importance of CD4 cell measurements for the scale-up of ART provision in resource-limited settings.

Original languageEnglish (US)
Pages (from-to)1208-1210
Number of pages3
JournalAIDS
Volume21
Issue number9
DOIs
StatePublished - May 2007

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda'. Together they form a unique fingerprint.

Cite this